Glythera makes Significant Appointment to Support Company Expansion

15th May 2015

Ian Evetts joins Glythera with over 20 years experience in the Pharmaceutical industry. He has a track record of senior strategic and operational roles including, Managing Director at Atebion BDS Ltd, Strategic Advisor at Bionure and Business Development and Portfolio Director at AstraZeneca. As Commercial Director of Glythera, he will provide strategic advice on developing the company’s technologies and therapies, a key growth area for Glythera.

Commenting on his appointment, Ian Evetts said, “Glythera is an innovative biotechnology company and their proprietary linker and stable glycan technologies represent a leap forward in the development of next generation therapies. I am extremely pleased to be involved at this exciting time for the company and I look forward to working with the team as it continues to expand and maximise new opportunities.”